Acute lymphoblastic leukemia (ALL) is the most common cancer of childhood and one of the deadliest despite impressive improvements in survival. The Davis lab uses single-cell, high-dimensional analysis to identify the most important cells, those that are resistant to standard and cutting-edge therapies, leading to relapse. By identifying and understanding these treatment resistant cells can we work to prevent relapse and cure more children and young adults with ALL.
A Continuing Medical Education activity presented by the Stanford University School of Medicine. View CE information and claim credit at https://stanford.cloud-cme.com/course/courseoverview?P=0&EID=42951